JCM
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JCM Accepts, published online ahead of print on 19 September 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01192-07v1
45/11/3589    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Artin, I.
Right arrow Articles by Holst, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Artin, I.
Right arrow Articles by Holst, E.

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.01192-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The first case of type E wound botulism was diagnosed using real-time PCR

Ingrid Artin, Per Björkman, Jonas Cronqvist, Peter Rådström, and Elisabet Holst*

Division of Medical Microbiology, Department of Laboratory Medicine, Lund University, SE-223 62 Lund, Sweden, Applied Microbiology, Lund Institute of Technology, Lund University, SE-221 00 Lund, Sweden,, Division of Infectious Diseases, Department of Clinical Sciences, Malmö University Hospital, Lund University, Malmö, Sweden

* To whom correspondence should be addressed. Email: Elisabet.Holst{at}med.lu.se.


   Abstract

Wound botulism is a growing problem among injecting drug users. The condition is often difficult to diagnose, with a laboratory confirmation in only 50% of the cases. We here present a real-time PCR-based method for diagnosis of wound botulism caused by Clostridium botulinum. The assay includes an internal amplification control which is co-amplified simultaneously with the genes encoding neurotoxin types A, B and E. This method was used to detect the first Swedish case of wound botulism in an injecting drug user. In addition, to the best of our knowledge, this is the first reported case of wound botulism caused by C. botulinum type E.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.